Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $1.78M | ﹤0.01% |
8,600
+1,100
| +15% | +$219K |
|
2102
Williams Companies
WMB
$87.8B
| $1.78M | ﹤0.01% |
38,900
-978,085
| -96% | -$43M |
|
2103
Adicet Bio
ACET
$74.1M
| $1.77M | ﹤0.01% |
76,975
-17,563
| -19% | -$393K |
|
|
NVRO
2104
DELISTED
NEVRO CORP.
NVRO
| $1.77M | ﹤0.01% |
316,919
-51,181
| -14% | -$358K |
|
2105
Colony Bankcorp
CBAN
$468M
| $1.76M | ﹤0.01% |
113,678
+18,600
| +20% | +$265K |
|
2106
Tidal Trust II Defiance Nasdaq 100 Weekly Distribution ETF
QQQY
$187M
| $1.76M | ﹤0.01% |
48,066
-54,934
| -53% | -$2.16M |
|
2107
Fossil Group
FOSL
$344M
| $1.75M | ﹤0.01% |
1,498,085
+12,500
| +0.8% | +$14.7K |
|
|
PINE
2108
Alpine Income Property Trust
PINE
$352M
| $1.75M | ﹤0.01% |
96,300
+54,741
| +132% | +$954K |
|
2109
Invesco FTSE RAFI US 1000 ETF
PRF
$9.95B
| $1.75M | ﹤0.01% |
43,000
+25,217
| +142% | +$989K |
|
|
BOW
2110
Bowhead Specialty Holdings
BOW
$1.12B
| $1.75M | ﹤0.01% |
+62,300
| New | +$1.75M |
|
2111
Vanguard FTSE Europe ETF
VGK
$31.1B
| $1.74M | ﹤0.01% |
+24,500
| New | +$1.68M |
|
2112
Mesa Laboratories
MLAB
$565M
| $1.74M | ﹤0.01% |
13,400
+11,000
| +458% | +$1.29M |
|
2113
Vishay Intertechnology
VSH
$5.03B
| $1.74M | ﹤0.01% |
91,925
+31,514
| +52% | +$656K |
|
2114
LCNB Corp
LCNB
$285M
| $1.74M | ﹤0.01% |
115,216
+300
| +0.3% | +$4.42K |
|
|
FBMS
2115
DELISTED
The First Bancshares, Inc.
FBMS
| $1.74M | ﹤0.01% |
+54,000
| New | +$1.67M |
|
2116
Xenon Pharmaceuticals
XENE
$6.24B
| $1.73M | ﹤0.01% |
44,000
-48,900
| -53% | -$1.97M |
|
|
DHC
2117
Diversified Healthcare Trust
DHC
$2.11B
| $1.73M | ﹤0.01% |
413,300
+316,600
| +327% | +$1.07M |
|
2118
iShares MSCI Italy ETF
EWI
$1.07B
| $1.73M | ﹤0.01% |
+44,300
| New | +$1.66M |
|
|
TECX
2119
Tectonic Therapeutic
TECX
$570M
| $1.72M | ﹤0.01% |
56,897
-32,132
| -36% | -$587K |
|
|
EVRI
2120
DELISTED
Everi Holdings
EVRI
| $1.72M | ﹤0.01% |
131,200
-155,800
| -54% | -$1.84M |
|
2121
BayCom
BCML
$335M
| $1.72M | ﹤0.01% |
72,600
-7,900
| -10% | -$177K |
|
2122
Gossamer Bio
GOSS
$87.2M
| $1.72M | ﹤0.01% |
1,744,805
-301,795
| -15% | -$290K |
|
2123
Lindblad Expeditions
LIND
$2.23B
| $1.72M | ﹤0.01% |
185,899
+146,199
| +368% | +$1.36M |
|
|
SII
2124
Sprott
SII
$2.9B
| $1.72M | ﹤0.01% |
39,700
+13,500
| +52% | +$571K |
|
|
VOXR
2125
Vox Royalty Corp
VOXR
$342M
| $1.71M | ﹤0.01% |
567,300
+375,800
| +196% | +$1.03M |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.